2020 Group Company Advanced Collective and Advanced Individual
Release time:
2021-02-10
2020 Advanced Collective and Advanced Individual of Group Company
1. Advanced Collective
Advanced Enterprise:
Daye Jianfeng Cement Co., Ltd. Yunnan Jianfeng Cement Co., Ltd.
Advanced Party Organization:
Party Branch of CPC Yunnan Jianfeng Cement Co., Ltd. Party Branch
Party Branch of CPC Zhejiang Jianfeng International Trade Co., Ltd. Party Branch
Advanced Civilization Workshop (Department):
Zhejiang Jianfeng International Trade Co., Ltd. Warehouse Operation Department
Zhejiang Jianfeng Communication Cable Co., Ltd. Cable Workshop
Guizhou Huangping Jianfeng Cement Co., Ltd. Comprehensive Management Department
Zhejiang Jianfeng Pharmaceutical Co., Ltd. Pharmaceutical Factory Comprehensive Preparation Workshop
Tianjin Jianfeng Natural Products Co., Ltd. Jianti Workshop
Advanced Civilization Team:
Zhejiang Jianfeng Communication Cable Co., Ltd. Comprehensive Financial Management Department
Yunnan Jianfeng Cement Co., Ltd. Production and Manufacturing Department Site Class
Zhejiang Jianfeng International Trade Co., Ltd. Office (document room)
Guizhou Huangping Jianfeng Cement Co., Ltd. Manufacturing Department Class A
Zhejiang Jianfeng Pharmaceutical Co., Ltd. Quality Department Center Laboratory
Jinhua Jianfeng Pharmacy Chain Co., Ltd
Daye Jianfeng Cement Co., Ltd. Area Machine Repair TeamZhejiang Jianfeng Health Technology Co., Ltd. Health Products Workshop Capsule Line Production Team
Advanced Trade Union Organization:
Yunnan Jianfeng Cement Co., Ltd. Trade Union Committee Daye Jianfeng Cement Co., Ltd. Trade Union Committee
2. Outstanding Individual
Outstanding Employee
Peak Health
Zhou Huijuan Peak International Trade Ruan Weihang
Daye Peak Wu Xinqiong Daye Peak Zhang GuoshengYunnan Peak Luo Zhirong Peak Pharmaceutical Factory Wang Junyang
Peak Cable Sheng Gao Cang Huang Ping Peak Yang Sen
Flanders Liu Hailong New Peak North Card Dong Li
Innovation Expert
Daye Peak Huang Yanming Yunnan Peak Building Xu Xin
Pharmaceutical Company Development Department Zhang Sihan Huang Ping Peak Wu Lihua
Pharmaceutical Company Quality Department Han Ying Peak Cable Shen Ke
Excellent Management Worker
Daye Peak Li Jiang
Peak International Trade Building
Peak Pharmaceutical Factory Zheng Kunwu
Outstanding Salesman
Daye Peak Wang Zhengjia Peak International Trade Fang Zhangli
Pharmaceutical Sales Company Jiang Sujian
Yunnan Peak Hu XiaodongPeak Cable Hu Longgang Huang Ping Peak Liu Jinpan
3. Advanced Individual
Outstanding Party Worker
Peak International Trade He Keqin Daye Peak wang Yuhua
Huang Ping Peak Qian Jiang
Outstanding Communist Party Member
Daye Peak Zhang Qingyu Yunnan Peak Yu Wei
Peak Pharmaceutical Factory Su Yuzhen Peak Health Zhou Guangming
Peak International Trade Xu Qin Huang Ping Peak Tong Yi
Outstanding Trade Union Worker
Daye Peak Yang Huiping Yunnan Peak Yang Shunchang
Trade Union Activists
peak International Trade Fang Xuming Peak Pharmaceutical Factory Fang Weiming
Advanced Worker of Safety and Environmental Protection
Peak Health Should Be Rich in Daye Peak Liu Chao
Yunnan Peak Bi Zhonghua Peak International Trade Ni Yingquan
Peak Cable Wang Debo
Rookie Staff
Yunnan Peak Qixianmei Jianfeng Group Dong Ban Fang Shi
Huang Ping Peak Wang Chenglong Peak Peak Ye Peak Fang Kai
pharmaceutical Factory Ni Zhenyu Peak Cable Huang Yuan
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31